Authors:
HOUBA PHJ
BOVEN E
LEENDERS RGG
VANDERMEULENMULLEMAN IH
SCHEEREN JW
PINEDO HM
HAISMA HJ
Citation: Phj. Houba et al., TUMOR SELECTIVE ACTIVATION OF A DOXORUBICIN PRODRUG (DOX-GA3) IN HUMAN OVARIAN-CANCER XENOGRAFTS, Annals of oncology, 9, 1998, pp. 194-194
Authors:
HAISMA HJ
BRAKENHOFF RH
VANDERMEULENMUILEMAN I
PINEDO HM
BOVEN E
Citation: Hj. Haisma et al., CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CARCINOMA ANTIBODY 323 A3 AND HUMAN BETA-GLUCURONIDASE/, Cancer immunology and immunotherapy, 45(5), 1998, pp. 266-272
Authors:
HAISMA HJ
SERNEE MF
HOOIJBERG E
BRAKENHOFF RH
VANDENMEULENMULLEMAN IH
PINEDO HM
BOVEN E
Citation: Hj. Haisma et al., CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CD20 ANTIBODY AND HUMAN BETA-GLUCURONIDASE FOR ANTIBODY-DIRECTEDENZYME PRODRUG THERAPY, Blood, 92(1), 1998, pp. 184-190
Authors:
STORM G
VINGERHOEDS MH
CROMMELIN DJA
HAISMA HJ
Citation: G. Storm et al., IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF ANTICANCER PRODRUGS, Advanced drug delivery reviews, 24(2-3), 1997, pp. 225-231
Authors:
MEIJS WE
HAISMA HJ
KLOK RP
VANGOG FB
KIEVIT E
PINEDO HM
HERSCHEID JDM
Citation: We. Meijs et al., ZIRCONIUM-LABELED MONOCLONAL-ANTIBODIES AND THEIR DISTRIBUTION IN TUMOR-BEARING NUDE-MICE, The Journal of nuclear medicine, 38(1), 1997, pp. 112-118
Citation: Phj. Houba et al., IMPROVED CHARACTERISTICS OF A HUMAN BETA-GLUCURONIDASE-ANTIBODY CONJUGATE AFTER DEGLYCOSYLATION FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUGTHERAPY, Bioconjugate chemistry, 7(5), 1996, pp. 606-611
Authors:
MEIJS WE
HAISMA HJ
VANDERSCHORS R
WIJBRANDTS R
VANDENOEVER K
KLOK RP
PINEDO HM
HERSCHEID JDM
Citation: We. Meijs et al., A FACILE METHOD FOR THE LABELING OF PROTEINS WITH ZIRCONIUM ISOTOPES, Nuclear medicine and biology, 23(4), 1996, pp. 439-448
Authors:
KIEVIT E
PINEDO HM
SCHLUPER HMM
HAISMA HJ
BOVEN E
Citation: E. Kievit et al., COMPARISON OF THE MONOCLONAL-ANTIBODIES 17-1A AND 323 A3 - THE INFLUENCE OF THE AFFINITY ON TUMOR UPTAKE AND EFFICACY OF RADIOIMMUNOTHERAPYIN HUMAN OVARIAN-CANCER XENOGRAFTS/, British Journal of Cancer, 73(4), 1996, pp. 457-464
Authors:
HOUBA PHJ
LEENDERS RGG
BOVEN E
SCHEEREN JW
PINEDO HM
HAISMA HJ
Citation: Phj. Houba et al., CHARACTERIZATION OF NOVEL ANTHRACYCLINE PRODRUGS ACTIVATED BY HUMAN BETA-GLUCURONIDASE FOR USE IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Biochemical pharmacology, 52(3), 1996, pp. 455-463
Authors:
LEENDERS RGG
SCHEEREN HW
HOUBA PHJ
BOVEN E
HAISMA HJ
Citation: Rgg. Leenders et al., SYNTHESIS AND EVALUATION OF NOVEL DAUNOMYCIN-PHOSPHATE-BETA-GLUCURONIDE, DAUNOMYCIN-PHOSPHATE-BETA-GLUCOSIDE, DAUNOMYCIN-SULFATE-BETA-GLUCURONIDE AND DAUNOMYCIN-SULFATE-BETA-GLUCOSIDE PRODRUGS FOR APPLICATION IN ADEPT, Bioorganic & medicinal chemistry letters, 5(24), 1995, pp. 2975-2980
Citation: Mr. Buist et al., MINOR HUMAN-ANTIBODY RESPONSE TO A MOUSE AND CHIMERIC MONOCLONAL-ANTIBODY AFTER A SINGLE IV INFUSION IN OVARIAN-CARCINOMA PATIENTS - A COMPARISON OF 5 ASSAYS, Cancer immunology and immunotherapy, 40(1), 1995, pp. 24-30
Authors:
HAISMA HJ
VANMUIJEN M
SCHEFFER G
SCHEPER RJ
PINEDO HM
BOVEN E
Citation: Hj. Haisma et al., A MONOCLONAL-ANTIBODY AGAINST HUMAN BETA-GLUCURONIDASE FOR APPLICATION IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Hybridoma, 14(4), 1995, pp. 377-382
Authors:
LEENDERS RGG
GERRITS KAA
RUIJTENBEEK R
SCHEEREN HW
HAISMA HJ
BOVEN E
Citation: Rgg. Leenders et al., BETA-GLUCURONYL CARBAMATE BASED PRO-MOIETIES DESIGNED FOR PRODRUGS INADEPT, Tetrahedron letters, 36(10), 1995, pp. 1701-1704
Authors:
MEIJS WE
HERSCHEID JDM
HAISMA HJ
WIJBRANDTS R
VANLANGEVELDE F
VANLEUFFEN PJ
MOOY R
PINEDO HM
Citation: We. Meijs et al., PRODUCTION OF HIGHLY PURE NO-CARRIER ADDED ZR-89 FOR THE LABELING OF ANTIBODIES WITH A POSITRON EMITTER, Applied radiation and isotopes, 45(12), 1994, pp. 1143-1147
Authors:
PLAIZIER MABD
ROOS JC
TEULE GJJ
VANDIEREN EB
DENHOLLANDER W
HAISMA HJ
DEJAGER RL
VANLINGEN A
Citation: Mabd. Plaizier et al., COMPARISON OF NONINVASIVE APPROACHES TO RED MARROW DOSIMETRY FOR RADIOLABELED MONOCLONAL-ANTIBODIES, European journal of nuclear medicine, 21(3), 1994, pp. 216-222
Authors:
VINGERHOEDS MH
HAISMA HJ
VANMUIJEN M
VANDERIJT RBJ
CROMMELIN DJA
STORM G
Citation: Mh. Vingerhoeds et al., A NEW APPLICATION FOR LIPOSOMES IN CANCER-THERAPY - IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF PRODRUGS, FEBS letters, 336(3), 1993, pp. 485-490